ReviewBiotechnology letters2025
Recent advances in microbial and bioelectrochemical strategies for degradation of per- and polyfluoroalkyl substances: mechanisms, limitations, and research opportunities.
Review in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Enzymatic Defluorination of Perfluorooctanoic Acid by an Evolutionarily Distinct Haloacid Dehalogenase.Research square · 2026Article
- Per- and polyfluoroalkyl substances (PFAS): persistence, toxicity, and emerging solutions.Bioprocess and biosystems engineering · 2026Review
- Current Research Advances and Future Prospects on Microbial Consortia for Sustainable PFAS Remediation.International journal of molecular sciences · 2026Review
- Microbial and molecular approaches for PFAS transformation in soils: prospects and limitations.RSC advances · 2026Review
- Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants characterized by strong carbon-fluorine bonds, making them resistant to conventional degradation methods. Their widespread detection in soil, water, and living organisms, coupled with significant potential health risks, has necessitated the development of effective remediation strategies. This review provides a detailed overview of recent advances in biotechnological approaches for PFAS degradation, with a focus on microbial and bioelectrochemical systems (BESs). Microbial species such as Pseudomonas and Acidimicrobium strains have demonstrated the ability to degrade PFAS under both aerobic and anaerobic conditions. Key enzymes, including dehalogenases and oxygenases, play a critical role in catalyzing the breakdown of PFAS. BESs technologies, including microbial fuel cells (MFCs) and microbial electrolysis cells (MECs), offer innovative solutions by combining microbial activity with electrochemical processes to enhance PFAS removal efficiency. Advanced BESs configurations, such as constructed wetland-MFCs, have further demonstrated the potential for enhanced PFAS removal through electrode adsorption and plant uptake. Despite significant progress, challenges remain, including PFAS toxicity, the complexity of environmental matrices, incomplete mineralization, scalability, and public safety concerns. Addressing these issues will require advancements in genetic engineering to develop robust microbial strains, optimization of BESs configurations, and integration with other advanced treatment technologies like advanced oxidation processes. Additionally, refining environmental factors such as pH, temperature, and the presence of humic substances is crucial for maximizing degradation efficiency. Future research should focus on scaling laboratory successes to field-scale applications, developing real-time monitoring tools for degradation processes, and addressing regulatory concerns. Through continuous innovation, biotechnological solutions offer a promising pathway to sustainable and effective PFAS remediation, addressing both environmental and public health concerns.
Indexed as
Identifiers
40323512What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.